Hiroshi HINOU

KAGAKU TO SEIBUTSU, 2024, 62, 393
DOI: 10.1271/kagakutoseibutsu.62.393

MUC1 and MUC16: critical for immune modulation in cancer therapeutics

Xinyi Chen, Ineza Karambizi Sandrine, Mu Yang, Jingyao Tu and Xianglin Yuan

Front. Immunol., 2024, 15
DOI: 10.3389/fimmu.2024.1356913

Decoding the Molecular Basis of the Specificity of an Anti-sTn Antibody

Cátia O. Soares, Maria Elena Laugieri, Ana Sofia Grosso, Mariangela Natale, Helena Coelho, Sandra Behren, Jin Yu, Hui Cai, Antonio Franconetti, Iker Oyenarte, Maria Magnasco, Ana Gimeno, Nuno Ramos, Wengang Chai, Francisco Corzana, Ulrika Westerlind, Jesús Jiménez-Barbero, Angelina S. Palma, Paula A. Videira, June Ereño-Orbea and Filipa Marcelo

JACS Au, 2025, 5, 225
DOI: 10.1021/jacsau.4c00921

Tumor-associated carbohydrate antigens of MUC1 – Implication in cancer development

Iwona Radziejewska

Biomedicine & Pharmacotherapy, 2024, 174, 116619
DOI: 10.1016/j.biopha.2024.116619

Characteristic Fragmentation Behavior of Linear and Cyclic O-Linked Glycopeptides and Their Peptide Skeletons in MALDI-TOF/TOF MS

Kohki Fukushi, Shogo Urakami and Hiroshi Hinou

Molecules, 2025, 30, 711
DOI: 10.3390/molecules30030711

Site-Specific O-Glycosylation in Oncofetal Fibronectin IIICS Domain Creates Cancer Stage-Specific Biomarkers

Nozomi Hirane, Yasuhiro Yokoi, Aiko Kobayashi, Misaki Yamada, Taiki Konno, Hiroyuki Kumeta, Hajime Wakui, Michiru Otaki, Yoshiaki Miura, Tatsuhiko Kakisaka, Toshiya Kamiyama, Akinobu Taketomi, Kazuhiro Nouso, Satoshi Kimura and Shin-Ichiro Nishimura

J. Am. Chem. Soc., 2025, 147, 12170
DOI: 10.1021/jacs.5c00333